The human landing catch (HLC) field trial, commonly referred to as the human-bait mosquito landing collection method, is the internationally recognized gold standard for evaluating topical repellent efficacy and monitoring host-seeking mosquito populations. By capturing mosquitoes as they land on exposed human skin, the method provides direct, quantifiable data on landing rates, complete protection time, and vector density that no mechanical trap can fully replicate. This article presents the technical principles, test sample categories, procedural protocols, quality controls, and practical applications of the method in line with WHO and EPA guidance.
Technical Overview
The human landing catch (HLC) method is an entomological field technique in which trained human volunteers serve as live bait and collectors capture host-seeking mosquitoes at the moment they land on exposed skin, before they take a blood meal. Because the method measures mosquito landing behavior on an actual human host under natural conditions, it is regarded as the reference standard against which mosquito repellents, personal protection products, and vector surveillance tools are validated.
The technique is grounded in the host-seeking behavior of adult female mosquitoes, which are attracted to humans by body heat, carbon dioxide, lactic acid, and other skin volatiles. In a typical trial, a collector exposes a defined area of skin (such as a forearm or lower leg) for fixed observation intervals and aspirates every mosquito that alights, transferring the specimens to labeled holding cages for counting and species identification. The resulting landing rate, expressed as mosquitoes per person-hour, or the complete protection time (CPT) of a repellent, provides objective evidence of product or vector control performance.
Key reference frameworks for this method include the WHO Guidelines for Efficacy Testing of Mosquito Repellents for Human Skin, the US EPA Product Performance Test Guideline OPPTS 810.3700 for skin-applied repellents, and national pesticide registration guidelines that adopt comparable protocols. Because human subjects are directly involved, all trials must be conducted under ethics committee approval, informed consent, and strict medical risk management.
Testing Samples
Topical Skin Repellents
Liquid, lotion, cream, stick, and spray formulations containing active ingredients such as DEET, icaridin (picaridin), IR3535, oil of lemon eucalyptus (PMD), or citronella oil. These products are applied to a standardized area of exposed skin to determine how long they prevent mosquito landings under field conditions.
Repellent-Treated Wearables and Textiles
Permethrin-impregnated clothing, treated wristbands, ankle bands, and patches. HLC trials assess whether treated materials reduce landings on adjacent or covered body areas and quantify the residual protection period after washing or extended use.
Spatial and Vaporizing Repellent Devices
Mosquito coils, vaporizing mats, liquid vaporizers, and passive emanator devices. Although primarily evaluated in semi-field chambers, these products are often supplemented with HLC measurements in open veranda or yard settings to confirm real-world biting suppression.
Wild Mosquito Populations for Surveillance
The method is also applied without any test product to sample natural vector populations, including Anopheles malaria vectors, Aedes aegypti and Aedes albopictus dengue vectors, and Culex species, generating baseline density and biting activity data.
Testing Items
Field trials based on the human landing catch method typically quantify the following parameters:
- Landing or biting rate: number of mosquitoes landing per collector per hour during defined exposure windows.
- Complete protection time (CPT): elapsed time from repellent application to the first confirmed landing or bite, with subsequent confirmatory landings.
- Percent repellency or percent protection: proportional reduction in landings on treated subjects relative to untreated control subjects.
- Species composition: identification of collected female mosquitoes to species or complex level using morphological keys or molecular methods.
- Circadian biting rhythm: landing rates stratified by hour to map peak activity periods, such as dusk, dawn, or nocturnal peaks.
- Residual efficacy duration: performance of the product over consecutive hours or days, including post-washing persistence for treated textiles.
- Environmental covariates: temperature, relative humidity, wind speed, and light level recorded concurrent with each exposure interval.
Testing Methods
Site Selection and Validation
Test sites are chosen in areas with high natural densities of the target mosquito species, representative local habitats, and landowner or community permission. A preliminary mosquito density survey is conducted using short control exposures; WHO guidance generally requires a minimum landing pressure of approximately 10 landings per 5-minute control exposure before a repellent trial is considered valid. Sites are re-validated each test day, and trials are suspended if density falls below the threshold.
Volunteer Recruitment and Ethics
Participants are healthy adults, typically aged 18 to 55, who provide written informed consent after receiving a full explanation of risks and protective measures. The study protocol, including prophylaxis policy, medical supervision, and withdrawal criteria, must be approved by an institutional ethics committee. Volunteers must avoid alcohol, perfumed cosmetics, and smoking before testing, and collectors are trained to capture mosquitoes before they bite, thereby minimizing disease exposure.
Exposure and Collection Procedure
A standardized skin area, commonly a forearm of approximately 600 square centimeters or a lower leg of up to 1,000 square centimeters, is washed with unscented soap and dried before the trial. In repellent tests, the product is applied at the label dose to the exposed area while the volunteer wears protective gloves and covers all untreated skin. Treated volunteers and untreated controls are positioned at fixed stations and exposed simultaneously in alternating sequences, for example 5 to 10 minutes of exposure every 30 to 60 minutes over the claimed protection period. Collectors use mechanical aspirators or oral aspirators equipped with collection tubes to capture every mosquito that lands, without allowing the mosquito to engorge.
Data Recording and Endpoints
All captured specimens are anesthetized or chilled, counted, labeled by station, subject, and time interval, and preserved for identification. The primary endpoint for repellents is the CPT, supported by landing-rate ratios between treated and control arms; for surveillance studies, the primary output is the person-hour landing rate by species and time slot. Environmental conditions are logged at each interval to support interpretation and comparability across test days.
Quality Control
- Use of paired or rotating treated and control subjects to neutralize site and individual attractiveness differences.
- Blind allocation of treated and untreated arms wherever feasible to reduce observer bias.
- Pre-trial collector training and inter-collector calibration on capture technique and timing.
- Daily verification of mosquito density thresholds with control exposures before product evaluation begins.
- Duplicate recording sheets and independent verification of specimen counts and species identifications.
Applications
The human landing catch field trial method supports a wide range of regulatory, public health, and research purposes:
- Registration of topical repellents with regulatory agencies, including the US EPA, EU authorities under the Biocidal Products Regulation, and national pesticide management agencies that require field efficacy data.
- Label claim substantiation for protection duration, such as 4-hour, 6-hour, or 8-hour claims on consumer repellent products.
- Personal protection validation for military personnel, forestry and agricultural workers, and travelers deployed to vector-borne disease endemic regions.
- Vector surveillance programs measuring Anopheles, Aedes, and Culex densities to guide malaria, dengue, and filariasis control interventions.
- Evaluation of integrated vector management strategies, including the residual impact of indoor residual spraying and long-lasting insecticidal nets on outdoor and residual biting.
- Entomological research on host preference, biting rhythms, and the behavioral effects of insecticide resistance in wild populations.
FAQ
Is the human landing catch method safe for volunteers?
When conducted under approved protocols, the risk is actively minimized. Collectors are trained to aspirate mosquitoes before they bite, volunteers receive appropriate prophylaxis where endemic disease risk exists, and medical supervision with defined withdrawal criteria is mandatory. Ethics review boards weigh these safeguards before approving any trial.
Why use human subjects instead of traps?
Mosquito host-seeking behavior is highly specific to human odors, and mechanical traps differ in sensitivity and species bias. HLC provides the only direct measurement of landing on a human host, which is the exact endpoint that repellent labels claim and that disease transmission models require.
How many volunteers and test days are required?
WHO and EPA repellent guidelines typically require a minimum of five or more human subjects per test product plus matched controls, replicated across several test days, with adequate landing pressure on each day to ensure statistical validity.
What alternatives exist when HLC is not permitted?
The human-baited double-net trap, BG-Sentinel trap, CDC light trap, and tent traps are frequently used alternatives. However, because they can diverge from true human landing rates, HLC remains the benchmark for calibrating and validating these substitute methods.
What defines the end of a repellent field trial?
The trial ends at the first confirmed protection failure, defined as a landing or bite followed by a confirmatory landing in the same or a subsequent exposure interval, or at the end of the claimed protection period if no failure occurs.